全文获取类型
收费全文 | 866篇 |
免费 | 150篇 |
出版年
2021年 | 9篇 |
2020年 | 5篇 |
2019年 | 6篇 |
2018年 | 11篇 |
2017年 | 9篇 |
2016年 | 15篇 |
2015年 | 29篇 |
2014年 | 32篇 |
2013年 | 46篇 |
2012年 | 48篇 |
2011年 | 45篇 |
2010年 | 41篇 |
2009年 | 27篇 |
2008年 | 38篇 |
2007年 | 32篇 |
2006年 | 47篇 |
2005年 | 38篇 |
2004年 | 24篇 |
2003年 | 36篇 |
2002年 | 42篇 |
2001年 | 41篇 |
2000年 | 40篇 |
1999年 | 39篇 |
1998年 | 21篇 |
1997年 | 19篇 |
1996年 | 16篇 |
1995年 | 11篇 |
1994年 | 10篇 |
1993年 | 8篇 |
1992年 | 20篇 |
1991年 | 10篇 |
1990年 | 18篇 |
1989年 | 22篇 |
1988年 | 15篇 |
1987年 | 15篇 |
1986年 | 15篇 |
1985年 | 8篇 |
1984年 | 14篇 |
1983年 | 8篇 |
1982年 | 16篇 |
1981年 | 6篇 |
1980年 | 8篇 |
1979年 | 5篇 |
1978年 | 7篇 |
1977年 | 6篇 |
1976年 | 5篇 |
1975年 | 6篇 |
1974年 | 5篇 |
1972年 | 3篇 |
1966年 | 3篇 |
排序方式: 共有1016条查询结果,搜索用时 15 毫秒
1.
Cytoplasmic dynein is responsible for transport of several viruses to the nucleus. Adenovirus recruits dynein directly. Transport depends on virus-induced activation of protein kinase A (PKA) and other cellular protein kinases, whose roles in infection are poorly understood. We find that PKA phosphorylates cytoplasmic dynein at a novel site in light intermediate chain 1 (LIC1) that is essential for dynein binding to the hexon capsid subunit and for virus motility. Surprisingly, the same LIC1 modification induces a slow, but specific, dispersal of lysosomes (lyso)/late endosomes (LEs) that is mediated by inhibition of a newly identified LIC1 interaction with the RILP (Rab7-interacting lysosomal protein). These results identify an organelle-specific dynein regulatory modification that adenovirus uses for its own transport. PKA-mediated LIC1 phosphorylation causes only partial lyso/LE dispersal, suggesting a role for additional, parallel mechanisms for dynein recruitment to lyso/LEs. This arrangement provides a novel means to fine tune transport of these organelles in response to infection as well as to developmental and physiological cues. 相似文献
2.
Reinhold Scherer Josef Faller Elisabeth V. C. Friedrich Eloy Opisso Ursula Costa Andrea Kübler Gernot R. Müller-Putz 《PloS one》2015,10(5)
Brain-computer interfaces (BCIs) translate oscillatory electroencephalogram (EEG) patterns into action. Different mental activities modulate spontaneous EEG rhythms in various ways. Non-stationarity and inherent variability of EEG signals, however, make reliable recognition of modulated EEG patterns challenging. Able-bodied individuals who use a BCI for the first time achieve - on average - binary classification performance of about 75%. Performance in users with central nervous system (CNS) tissue damage is typically lower. User training generally enhances reliability of EEG pattern generation and thus also robustness of pattern recognition. In this study, we investigated the impact of mental tasks on binary classification performance in BCI users with central nervous system (CNS) tissue damage such as persons with stroke or spinal cord injury (SCI). Motor imagery (MI), that is the kinesthetic imagination of movement (e.g. squeezing a rubber ball with the right hand), is the "gold standard" and mainly used to modulate EEG patterns. Based on our recent results in able-bodied users, we hypothesized that pair-wise combination of "brain-teaser" (e.g. mental subtraction and mental word association) and "dynamic imagery" (e.g. hand and feet MI) tasks significantly increases classification performance of induced EEG patterns in the selected end-user group. Within-day (How stable is the classification within a day?) and between-day (How well does a model trained on day one perform on unseen data of day two?) analysis of variability of mental task pair classification in nine individuals confirmed the hypothesis. We found that the use of the classical MI task pair hand vs. feed leads to significantly lower classification accuracy - in average up to 15% less - in most users with stroke or SCI. User-specific selection of task pairs was again essential to enhance performance. We expect that the gained evidence will significantly contribute to make imagery-based BCI technology become accessible to a larger population of users including individuals with special needs due to CNS damage. 相似文献
3.
Ralf J. Jäger Vincent R. Harley Rudolf A. Pfeiffer Peter N. Goodfellow Gerd Scherer 《Human genetics》1992,90(4):350-355
A familial mutation in SRY, the gene coding for the testis-determining factor TDF, was identified in an XY female with gonadal dysgenesis, her father, her two brothers and her uncle. The mutation consists of a T to C transition in the region of the SRY gene coding for a protein motif known as the high mobility group (HMG) box, a protein domain known to confer DNA-binding specificity on the SRY protein. This point mutation results in the substitution, at amino acid position 109, of a serine residue for phenylalanine, a conserved aromatic residue in almost all HMG box motifs known. This F109S mutation was not found in 176 male controls. When recombinant wildtype SRY and SRYF109S mutant protein were tested in vitro for binding to the target site AAC AAAG, no differences in DNA-binding activity were observed. These results imply that the F109S mutation either is a rare neutral sequence variant, or produces an SRY protein with slightly altered in vivo activity, the resulting sex phenotype depending on the genetic back-ground or environmental factors.This paper is dedicated by G. S. to Professor Ulrich Wolf on the occasion of his 60th birthday 相似文献
4.
5.
Thomas K?tter Bruno R. da Costa Margrit F?ssler Eva Blozik Klaus Linde Peter Jüni Stephan Reichenbach Martin Scherer 《PloS one》2015,10(4)
Background
Metamizole is used to treat pain in many parts of the world. Information on the safety profile of metamizole is scarce; no conclusive summary of the literature exists.Objective
To determine whether metamizole is clinically safe compared to placebo and other analgesics.Methods
We searched CENTRAL, MEDLINE, EMBASE, CINAHL, and several clinical trial registries. We screened the reference lists of included trials and previous systematic reviews. We included randomized controlled trials that compared the effects of metamizole, administered to adults in any form and for any indication, to other analgesics or to placebo. Two authors extracted data regarding trial design and size, indications for pain medication, patient characteristics, treatment regimens, and methodological characteristics. Adverse events (AEs), serious adverse events (SAEs), and dropouts were assessed. We conducted separate meta-analyses for each metamizole comparator, using standard inverse-variance random effects meta-analysis to pool the estimates across trials, reported as risk ratios (RRs). We calculated the DerSimonian and Laird variance estimate T2 to measure heterogeneity between trials. The pre-specified primary end point was any AE during the trial period.Results
Of the 696 potentially eligible trials, 79 trials including almost 4000 patients with short-term metamizole use of less than two weeks met our inclusion criteria. Fewer AEs were reported for metamizole compared to opioids, RR = 0.79 (confidence interval 0.79 to 0.96). We found no differences between metamizole and placebo, paracetamol and NSAIDs. Only a few SAEs were reported, with no difference between metamizole and other analgesics. No agranulocytosis or deaths were reported. Our results were limited by the mediocre overall quality of the reports.Conclusion
For short-term use in the hospital setting, metamizole seems to be a safe choice when compared to other widely used analgesics. High-quality, adequately sized trials assessing the intermediate- and long-term safety of metamizole are needed. 相似文献6.
7.
Effect of Monochromatic Light on Proton Efflux of the Blue-Green Alga Anabaena variabilis 总被引:2,自引:2,他引:0 下载免费PDF全文
Light-induced proton efflux of Anabaena variabilis was found to be biphasic, the second phase being inhibited by the ATPase inhibitor nitrofen (2,4-dichloro-1-[4-nitrophenoxy]benzene). The first, fast phase was triggered by monochromatic light of 707 nanometers, whereas the second, slower phase was not. With 707 nanometers, light, respiratory O2 uptake was inhibited. Using light composed of two wavelengths (616 and 707 nanometers) a marked enhancement of both O2 evolution as well as the second phase of proton efflux was observed. The first phase was not enhanced. Thus, phase II is driven by both photosystems. As concluded from the action spectrum phase I is markedly determined by photosystem-I activity. Altogether the data show that two different mechanisms of light-induced proton efflux exist on the cytoplasmic membrane of Anabaena, the slower one being dependent on ATP and linear photosynthetic electron flow. 相似文献
8.
Intervention with mesenchymal stem cells (MSCs) represents a promising therapeutic tool in treatment-refractory autoimmune
diseases. A new report by Schurgers and colleagues in a previous issue of Arthritis Research & Therapy sheds novel mechanistic insight into the pathways employed by MSCs to suppress T-cell proliferation in vitro, but, at the same time, indicates that MSCs do not influence T-cell reactivity and the disease course in an in vivo arthritis model. Such discrepancies between the in vitro and in vivo effects of potent cellular immune modulators should spark further research and should be interpreted as a sign of caution
for the in vitro design of MSC-derived interventions in the setting of human autoimmune diseases. 相似文献
9.
Vanadate-sensitive proton efflux by filamentous cyanobacteria 总被引:1,自引:0,他引:1
Abstract Light-induced proton efflux has been investigated with intact cells of Anabaena, Nostoc, Anacystis , and Aphanocapsa . The proton efflux by filamentous blue-green algae is biphasic, strongly inhibited by ortho -vanadate and insensitive to cyanide. These data are taken as evidence for a proton-pumping ATP-hydrolase present on the cytoplasmic membrane of Anabaena and Nostoc . 相似文献
10.
Jennifer W. Hill Carol F. Elias Makoto Fukuda Kevin W. Williams Eric D. Berglund William L. Holland You-Ree Cho Jen-Chieh Chuang Yong Xu Michelle Choi Danielle Lauzon Charlotte E. Lee Roberto Coppari James A. Richardson Jeffrey M. Zigman Streamson Chua Philipp E. Scherer Bradford B. Lowell Jens C. Brüning Joel K. Elmquist 《Cell metabolism》2010,11(4):286-297